Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Labbate

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Urology Oncology|November 1, 2025
Genotype-Phenotype Characterization of Lynch Syndrome-associated Upper Tract Urothelial CarcinomaCraig Labbate, Daniel A Igel, Donika Saporito, et al.
JAMA Network Open|December 28, 2019
Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer DiagnosisRong Na, Craig Labbate, Hongjie Yu, et al.
European Urology Focus|April 14, 2023
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade DiseaseKyle M Rose, Katie S Murray, Craig Labbate, et al.
The Journal of Urology|January 19, 2023
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial CarcinomaCraig Labbate, Solomon Woldu, Katie Murray, et al.
European Urology Oncology|February 2, 2024
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal FunctionPatrick J Hensley, Craig Labbate, Andrew Zganjar, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Urologic Oncology|November 24, 2022
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomesSolomon L Woldu, Craig Labbate, Katie S Murray, et al.
Urologic Oncology|August 26, 2025
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysisJaime O Herrera-Caceres, Marian Wettstein, Surena F Matin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Urology Oncology|November 1, 2025
Genotype-Phenotype Characterization of Lynch Syndrome-associated Upper Tract Urothelial CarcinomaCraig Labbate, Daniel A Igel, Donika Saporito, et al.
JAMA Network Open|December 28, 2019
Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer DiagnosisRong Na, Craig Labbate, Hongjie Yu, et al.
European Urology Focus|April 14, 2023
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade DiseaseKyle M Rose, Katie S Murray, Craig Labbate, et al.
The Journal of Urology|January 19, 2023
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial CarcinomaCraig Labbate, Solomon Woldu, Katie Murray, et al.
European Urology Oncology|February 2, 2024
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal FunctionPatrick J Hensley, Craig Labbate, Andrew Zganjar, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Urologic Oncology|November 24, 2022
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomesSolomon L Woldu, Craig Labbate, Katie S Murray, et al.
Urologic Oncology|August 26, 2025
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysisJaime O Herrera-Caceres, Marian Wettstein, Surena F Matin, et al.
Pageof 3